Related Experiment Video

Updated: Jun 25, 2026

Real-time Analyses of Retinol Transport by the Membrane Receptor of Plasma Retinol Binding Protein
14:32

Real-time Analyses of Retinol Transport by the Membrane Receptor of Plasma Retinol Binding Protein

Published on: January 28, 2013

The novel RARbeta isoform (beta5) is a potential target of retinoids in breast cancer

Konstantin Christov1

  • 1Department of Surgical Oncology and Cancer Center, University of Illinois at Chicago, 840 South Wood Street, Chicago, IL 60612, USA. christov@uic.edu

Current Cancer Drug Targets
|March 12, 2009
PubMed

Insights

Retinoic acid receptor beta 2 (RARbeta2) is typically absent in breast tumors. A newly identified RARbeta5 isoform in breast cancer cells may indicate resistance to retinoid therapy, aiding patient selection for clinical trials.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Retinoic acid receptor beta 2 (RARbeta2) is a known tumor suppressor, typically expressed in normal cells but absent in most cancers, including breast cancer.
  • The absence of RARbeta2 in tumors suggests its potential role in cancer development and progression.

Purpose of the Study:

  • To review the expression of novel RARbeta isoforms (RARbeta5, RARbeta4, and RARbeta') in breast cancer cell lines.
  • To investigate the potential of RARbeta5 as a biomarker for retinoid resistance in breast cancer.

Main Methods:

  • Literature review of studies examining RARbeta isoform expression in breast cancer cell lines.
  • Analysis of expression data for RARbeta5, RARbeta4, and RARbeta' isoforms.

Main Results:

  • A novel RARbeta isoform, RARbeta5, was identified in breast cancer cells.
  • Expression patterns of RARbeta5, RARbeta4, and RARbeta' were summarized across various breast cancer cell lines.
  • RARbeta5 expression was found to potentially correlate with retinoid resistance in breast cancer cells.

Conclusions:

  • RARbeta5 may serve as a predictive biomarker for retinoid treatment response in breast cancer patients.
  • Identifying patients likely to benefit from retinoid therapy can be improved by assessing RARbeta5 expression.
  • Further research into RARbeta5's role could inform retinoid-based cancer prevention and therapy strategies.

More Related Videos

Methodology for Studying Interactions of Vitamin A Membrane Receptors and Opsin Protein with their Ligands in Generating the Retinylidene Protein08:18

Methodology for Studying Interactions of Vitamin A Membrane Receptors and Opsin Protein with their Ligands in Generating the Retinylidene Protein

Published on: October 4, 2024

An In Vitro Dormancy Model of Estrogen-sensitive Breast Cancer in the Bone Marrow: A Tool for Molecular Mechanism Studies and Hypothesis Generation08:48

An In Vitro Dormancy Model of Estrogen-sensitive Breast Cancer in the Bone Marrow: A Tool for Molecular Mechanism Studies and Hypothesis Generation

Published on: June 30, 2015

Related Concept Videos

The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Transducer Mechanism: Nuclear Receptors01:31

Transducer Mechanism: Nuclear Receptors

Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...